Coverage
GHMAP structures market-access intelligence across 35 country markets. Every data point is sourced from official authorities, tagged with source type and review status, and reviewed by qualified professionals before it is used.
Coverage registry
35 country markets · 7 regions
Source status ladder
Record rule
No field is shown as verified before professional review
Country markets in the registry
Tier-1 full profiles
Intelligence types per market
Regions covered
Counts reflect the GHMAP country registry, not market share or outcomes.
What we cover
For each country in the GHMAP registry, intelligence is structured across every dimension a healthcare manufacturer, distributor, or investor needs before committing to a market.
Applicable registration pathway per product category and country. Required submissions, technical file expectations, approval timelines, and local representative requirements — sourced from official regulator publications.
Open medical device registration pathwaysPublic vs. private payer mix, DRG codes, HTA requirements, reimbursement pathway questions, and budget-impact expectations. Identifies where reimbursement is automatic, negotiated, or absent.
Who actually pays for healthcare products in each market — public health system, insurance, out-of-pocket, tender, or procurement. Identifies the decision-maker chain before any commercial commitment.
Country-specific distributor qualification signals: required certifications, regulatory capability, hospital reach, and market coverage. Enables structured distributor search and evaluation.
Key Opinion Leader identification per specialty and country. Clinical advisory context, institutional affiliations, and product review participation — structured for market-access advisory engagement.
Market size, growth rate, population data, and competitive landscape signals — organized per country and product category to support prioritization decisions.
Local evidence expectations — what clinical or health economic evidence is required or expected for regulatory or reimbursement success in each market. Identifies gaps before submission.
Every data point is tagged with source type, publication date, and review status. Information from official regulators, government ministries, and payer authorities is distinguished from secondary or unverified sources.
Geographic coverage
Every country in the GHMAP registry carries a full intelligence profile — regulatory pathways, reimbursement structures, payer landscapes, and distributor readiness. Source status and review status stay visible on every country record.
CE marking pathways, HTA frameworks (G-BA, HAS, NICE), DRG structures, and national payer landscapes.
PMDA, KFDA, CDSCO, TGA, NMPA pathways with market-size data, distributor landscapes, and KOL network intelligence.
Regulatory pathway, procurement, and distributor readiness intelligence for key African healthcare markets.
ANVISA, COFEPRIS, INVIMA pathways documented alongside distributor qualification requirements and public tender structures.
SFDA, DHA, MOH approval pathways, GCC mutual recognition, and private-hospital procurement structures.
FDA 510(k), PMA, De Novo, Health Canada pathways, CMS reimbursement codes, and payer landscape intelligence.
TGA approval pathways, Medicare Benefits Schedule context, and distributor landscape intelligence.
Start with EU MDR Class IIa medical device registration, FDA 510(k) Class II registration, or SFDA Class IIb registration. Illustrative planning pages — professional review required before business use.
Source governance
GHMAP does not publish intelligence without verifying its source. Each record carries source type, publication date, and review status. No information is presented as verified until a qualified professional has reviewed it.
Data point identified but official source not yet attached
Official source attached, pending professional review
Under active professional review by a qualified local reviewer
Confirmed by a qualified professional. Ready for business use.
Previously reviewed content flagged for re-verification
Source confirmed outdated. Replacement sourcing underway.
Accepted source types
Reviewed launch planning
GHMAP organizes source status, evidence gaps, review needs, and next actions for market-access planning.
Professional review is required before business use.
